PPARγ transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons

被引:66
作者
Du, Jing [1 ]
Zhang, Lang [1 ]
Liu, Shubo [1 ]
Zhang, Chi [1 ]
Huang, Xiuqing [2 ,3 ]
Li, Jian [2 ,3 ]
Zhao, Naming [1 ]
Wang, Zhao [1 ]
机构
[1] Tsinghua Univ, Prot Sci Key Lab, Minist Educ, Dept Biol Sci & Biotechnol,Sch Med, Beijing 100084, Peoples R China
[2] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China
[3] Beijing Inst Geriatr, Minist Hlth, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
Insulin-degrading enzyme; Peroxisome proliferator-activated receptor gamma; Type 2 diabetes mellitus; Alzheimer's disease; Transcriptional regulation; ACTIVATED-RECEPTOR-GAMMA; ONSET ALZHEIMERS-DISEASE; DIABETES SUSCEPTIBILITY; GENE; ASSOCIATION; DEGRADATION; MICE; CANDIDATE; SEQUENCE; LINKAGE;
D O I
10.1016/j.bbrc.2009.04.047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-degrading enzyme (IDE) is a protease that has been demonstrated to play a key role in degrading both A beta and insulin and deficient in IDE function is associated with Alzheimer's disease (AD) and type 2 diabetes mellitus (DM2) pathology. However, little is known about the cellular and molecular regulation of IDE expression. Here we show IDE levels are markedly decreased in DM2 patients and positively correlated with the peroxisome proliferator-activated receptor gamma (PPAR gamma) levels. Further studies show that PPAR gamma plays an important role in regulating IDE expression in rat primary neurons through binding to a functional peroxisome proliferator-response element (PPRE) in IDE promoter and promoting IDE gene transcription. Finally, we demonstrate that PPAR gamma participates in the insulin-induced IDE expression in neurons. These results suggest that PPAR gamma transcriptionally induces IDE expression which provides a novel mechanism for the use of PPAR gamma agonists in both DM2 and AD therapies. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:485 / 490
页数:6
相关论文
共 23 条
[1]   Ligand-independent activation of peroxisome proliferator-activated receptor-γ by insulin and C-peptide in kidney proximal tubular cells -: Dependent on phosphatidylinositol 3-kinase activity [J].
Al-Rasheed, NM ;
Chana, RS ;
Baines, RJ ;
Willars, GB ;
Brunskill, NJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) :49747-49754
[2]   Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice [J].
Berger, J ;
Bailey, P ;
Biswas, C ;
Cullinan, CA ;
Doebber, TW ;
Hayes, NS ;
Saperstein, R ;
Smith, RG ;
Leibowitz, MD .
ENDOCRINOLOGY, 1996, 137 (10) :4189-4195
[3]   Evidence for genetic linkage of Alzheimer's disease to chromosome 10q [J].
Bertram, L ;
Blacker, D ;
Mullin, K ;
Keeney, D ;
Jones, J ;
Basu, S ;
Yhu, S ;
McInnis, MG ;
Go, RCP ;
Vekrellis, K ;
Selkoe, DJ ;
Saunders, AJ ;
Tanzi, RE .
SCIENCE, 2000, 290 (5500) :2302-+
[4]   Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-ε4 allele [J].
Cook, DG ;
Leverenz, JB ;
McMillan, PJ ;
Kulstad, JJ ;
Ericksen, S ;
Roth, RA ;
Schellenberg, GD ;
Jin, LW ;
Kovacina, KS ;
Craft, S .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01) :313-319
[5]   Insulin degradation: Progress and potential [J].
Duckworth, WC ;
Bennett, RG ;
Hamel, FG .
ENDOCRINE REVIEWS, 1998, 19 (05) :608-624
[6]   Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees [J].
Ertekin-Taner, N ;
Graff-Radford, N ;
Younkin, LH ;
Eckman, C ;
Baker, M ;
Adamson, J ;
Ronald, J ;
Blangero, J ;
Hutton, M ;
Younkin, SG .
SCIENCE, 2000, 290 (5500) :2303-+
[7]   Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats [J].
Fakhrai-Rad, H ;
Nikoshkov, A ;
Kamel, A ;
Fernström, M ;
Zierath, JR ;
Norgren, S ;
Luthman, H ;
Galli, J .
HUMAN MOLECULAR GENETICS, 2000, 9 (14) :2149-2158
[8]   Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo [J].
Farris, W ;
Mansourian, S ;
Chang, Y ;
Lindsley, L ;
Eckman, EA ;
Frosch, MP ;
Eckman, CB ;
Tanzi, RE ;
Selkoe, DJ ;
Guénette, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4162-4167
[9]   Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility [J].
Groves, CJ ;
Wiltshire, S ;
Smedley, D ;
Owen, KR ;
Frayling, TM ;
Walker, M ;
Hitman, GA ;
Levy, JC ;
O'Rahilly, S ;
Menzel, S ;
Hattersley, AT ;
McCarthy, MI .
DIABETES, 2003, 52 (05) :1300-1305
[10]   DEGRADATION OF INTRAENDOSOMAL INSULIN BY INSULIN-DEGRADING ENZYME WITHOUT ACIDIFICATION [J].
HAMEL, FG ;
MAHONEY, MJ ;
DUCKWORTH, WC .
DIABETES, 1991, 40 (04) :436-443